Aeterna Zentaris : Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Outlook - Form 6-K

Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Outlook


- Continue to advance and expand opportunities with established... | April 3, 2022

Related Keywords

Germany ,Australia ,United States ,United Kingdom ,Massachusetts ,Boston ,Bulgaria ,Canada ,Russia ,Toronto ,Ontario ,South Korea ,Turkey ,Ukraine ,Russian ,Republic Of Korea ,America ,Canadian ,Lou Gehrig ,Jenene Thomas ,Thomas Rudel ,Joerg Wischhusen ,Klaus Paulini ,Linkedin ,Aeterna Zentaris ,Twitter ,University Of Queensland ,Kim Pharmaceuticals Bulgaria ,Nk Meditech Ltd ,Nasdaq ,Aeterna Zentaris Inc ,Vaccine Development Pipeline ,European Union ,Facebook ,Therapeutics Development Pipeline ,University Hospital In Wuerzburg ,European Commission ,University Of Sheffield ,University Of Wuerzburg ,Toronto Stock Exchange ,Diagnostics Development Pipeline ,Novo Nordisk ,Aeterna Zentaris Reports Fourth Quarter ,Full Year ,Provides Business ,Chief Executive Officer ,Julius Maximilians University Wuerzburg ,Giuliano La Fratta ,Chief Financial ,Clinical Programs Update ,University Hospital ,Michael Levy ,Massachusetts General Hospital ,Auto Immunity Modifying Biologicals ,Clearance Parathyroid Hormone ,Fusion Polypeptides ,North America ,New Drug Application ,Er Kim Pharmaceuticals Bulgaria ,Vaccine Platform ,Fourth Quarter ,Financial Statements ,Financial Condition ,Litigation Reform Act ,Novo Amended License Agreement ,Annual Report ,Aeterna Zentaris Inc Stock Exchange ,News ,Information ,Press Release ,Eterna ,Centaris ,Reports ,Fourth ,Quarter ,End ,Bull ,Ear ,021 ,Financial ,Results ,Rovides ,Business ,Ontinue ,O ,Advance ,Xpand ,Opportunities ,Ith Aezs Ca0079754028 ,